Immunogenicity and Safety of Biological E’s 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14®) Administered in a 2p+1 Schedule to Healthy Infants: A Multicenter, Randomized, Active Controlled, Single-Blind, Phase III Trial

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.